ABCL - 853
Vispa-cel, an Allogeneic Anti-CD19 CAR-T Cell Therapy with a PD-1 Knockout, in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER Phase 1 Clinical Trial)
Mohamad Cherry
Poster Presenter: Mohamad Cherry
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
Showing 1 result for author "Mohamad Cherry".
ABCL - 853
Mohamad Cherry
Poster Presenter: Mohamad Cherry
This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.